Get the Stockscreener App
2.79
2.79%
-0.08
After Hours:
2.79
Burning Rock Biotech Ltd Adr stock is traded at $2.79, with a volume of 32,902.
It is down -2.79% in the last 24 hours and down -34.66% over the past month.
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
See More
Previous Close:
$2.87
Open:
$2.91
24h Volume:
32,902
Relative Volume:
2.63
Market Cap:
$29.13M
Revenue:
$71.19M
Net Income/Loss:
$-59.54M
P/E Ratio:
-0.4805
EPS:
-5.8068
Net Cash Flow:
$-18.58M
1W Performance:
-1.76%
1M Performance:
-34.66%
6M Performance:
-0.36%
1Y Performance:
-63.22%
1-Day Range:
$2.79
$2.92
1-Week Range:
$2.79
$3.18
52-Week Range:
$2.62
$8.99
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Name
Burning Rock Biotech Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare BNR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
2.79 | 29.13M | 71.19M | -59.54M | -18.58M | -5.8068 |
|
TMO
Thermo Fisher Scientific Inc
|
423.55 | 160.15B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
199.05 | 141.09B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
471.90 | 35.45B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
108.63 | 30.37B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.48 | 26.50B | 15.41B | 1.37B | 2.11B | 7.50 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jul-07-20 | Initiated | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Stock (BNR) Latest News
Burning Rock Biotech LtdADR to Host Earnings Call - ACCESS Newswire
Burning Rock Announces Results of 2024 Annual General Meeting - Marketscreener.com
Burning Rock Announces Results of 2024 Annual General Meeting - GlobeNewswire Inc.
Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Canada Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech CFO Leo Li resigns - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Viant Technology (DSP) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Burning Rock Biotech Limited Sponsored ADR (BNR) Reports Q2 Loss, Tops Revenue Estimates - Nasdaq
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - USC-China Institute
Transcript : Burning Rock Biotech Limited, Q4 2021 Earnings Call, Mar 22, 2022 - Marketscreener.com
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod - Benzinga
Citi Appointed Depositary Bank for Burning Rock Biotech Limited’s Sponsored ADR Program - Business Wire
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO - Benzinga
Burning Rock Biotech Ltd Adr Stock (BNR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):